BCL2 and acute lymphoblastic leukemia: In conclusion, the available evidence suggests that proteins involved in the intrinsic apoptosis pathway, particularly those in the BCL-2 superfamily, play a crucial role in the development of both AML and ALL, justifying their use as therapeutic targets [43].